In vivo inhibition of antiphospholipid antibody-induced pathogenicity utilizing the antigenic target peptide domain I of beta2-glycoprotein I: proof of concept - Ioannou, Y; Romay-Penabad, Z; Pericleous, C (J Thromb Haemost, 2009)
, et al.